We would like to keep our patients, families and professionals up to date with the latest developments in our research.
We may sometimes highlight particular “news reports” that may appear in the media, as there may be general points that are worth emphasising or challenging.
US FDA has approved Setmelanotide for patients with obesity due to POMC, PCSK1 or LEPR deficiency
Prof Sadaf Farooqi awarded the highest honour bestowed by the Society for Endocrinology
With colleagues, we showed that Setmelanotide is effective in treating severe obesity caused by POMC or LEPR deficiency
New research that the Farooqi Lab contributed to shows that maternally inherited mutations in the Trappc9 gene can cause obesity and behavioural changes.
We recently expanded on our understanding of how genetic alterations in BDNF/TrkB contribute to obesity and behavioural difficulties.
We recently identified three genes called PHIP, DGKI, ZMYM4 which may play an important role in controlling a person’s weight.
We used metabolomics to study the changes that occur when overweight people are treated with leptin
As part of Mental Health Awareness Week (Monday 18th May – Friday 22nd May), the Cambridge University Sports Centre is running a Virtual Climbing Challenge. They are challenging individuals and teams to choose a target of climbing a building, set of buildings, or even a mountain – all virtually. Participants can climb the stairs in their house or the hill in their local park.
Raising funds for high-grade Personal Protective Equipment (PPE) for health and social care professionals caring for patients with COVID-19 in Cambridge and the East of England.
Report by an international group of Clinicians highlights how the caring professions are failing people with obesity.
Important to understand that obesity is complex and people should not be stigmatised.
A recent statement written by 30 experts across Europe identified variables that should be included in all obesity trials.
We recently expanded on our understanding of how genetic alterations in SH2B1 contribute to obesity and neurobehavioral difficulties.
Two of our young patients recently visited us to help make a short film about what it’s like to come to Cambridge and be part of our research. Check it out and meet some of our team at What happens when I come to Cambridge.
Professor Farooqi was at the University of Wolverhampton on Thursday 19 September 2019, being awarded an Honorary Doctorate of Science in recognition of her contributions to biomedical science and her longstanding connection with the Midlands.
Prof. Sadaf Farooqi has been elected as a member of EMBO, an organisation of the best researchers in Europe and around the world
Many different variants in the MC4R gene are known to lead to early onset obesity in people. Excitingly, we have now been able to demonstrate that some variants have the opposite effect and may protect people from becoming overweight.
We recently described the mechanism through which Steroid Receptor Coactivator (SRC)-1 regulates appetite and body weight.
We recently discovered why some people manage to stay thin while others gain weight.